Cytosorbents Crp Earnings Estimate

CTSO Stock  USD 1.06  0.01  0.93%   
By analyzing Cytosorbents Crp's earnings estimates, investors can diagnose different trends across Cytosorbents Crp's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Cytosorbents Crp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
Cytosorbents Crp is projected to generate 0.0 in earnings per share on the 31st of December 2024. Cytosorbents Crp earnings estimates show analyst consensus about projected Cytosorbents Crp EPS (Earning Per Share). It derives the highest and the lowest estimates based on Cytosorbents Crp's historical volatility. Many public companies, such as Cytosorbents Crp, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Cytosorbents Crp's earnings estimates, investors can diagnose different trends across Cytosorbents Crp's analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Cytosorbents Crp's Gross Profit is very stable compared to the past year. As of the 1st of March 2025, Gross Profit Margin is likely to grow to 0.58, while Pretax Profit Margin is likely to drop (0.76).
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.

Cytosorbents Crp Earnings per Share Projection vs Actual

About Cytosorbents Crp Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Cytosorbents Crp earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Cytosorbents Crp estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Cytosorbents Crp fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-254.3 M-241.5 M
Retained Earnings Total Equity-228.6 M-217.2 M
Earnings Yield(0.52)(0.49)
Price Earnings Ratio(1.56)(1.64)
Price Earnings To Growth Ratio 0.12  0.11 
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.36)
Revenue Per Share
0.72
Quarterly Revenue Growth
0.066
Return On Assets
(0.28)
Return On Equity
(1.19)
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.